Menu
Manual Lymphatic Drainage is a gentle, rhythmical manual therapy technique designed to stimulate lymph vessel contraction, redirect lymph fluid toward healthy drainage pathways, and reduce interstitial fluid build-up.
Unlike deep massage, MLD works at a superficial tissue level, targeting lymph capillaries located just beneath the skin.
MLD is widely used in medical settings for:
Primary lymphoedema (congenital or idiopathic lymphatic dysfunction).
Secondary lymphoedema (post-surgical, post-cancer treatment, trauma, or infection).
Chronic swelling, heaviness, and tissue fibrosis.
Mr Salus Sporting Lab has now opened a new Clinic in Brixton, where our expert massage therapists will provide our patients with Manual Lymphatic Drainage.
We have equipped our massage therapy room with a special massage therapy bed, which allows our therapists to lift legs and body to improve the lymphatic drainage.
At Mr Salus Sporting Lab, our massage therapists have been trained to perform a special Instrument Assisted Manual Lymphatic Drainage, which facilitates and improves the absorption of the excessive fluid accumulated in different body parts.
Mr Salus Sporting Lab has now opened a new clinic in central London, close to Bank Station and Cannon Street Station.
We have equipped this therapy clinic with a proprietary therapy bed technology, which allows our expert massage therapist to move legs with a 360-degree range of motion to help them perform a unique and more effective Manual Lymphatic Drainage.
The lymphatic system plays a critical role in:
When lymphatic flow is impaired, fluid accumulation, tissue fibrosis, and chronic swelling can occur — clinically known as lymphoedema.
At Mr Salus Sporting Lab, we use Manual Lymphatic Drainage (MLD) as a cornerstone treatment, integrating it with advanced physiotherapy techniques and Shockwave Therapy to address both primary and secondary lymphoedema in a safe, evidence-informed way.
This approach builds directly on the principles discussed in our previous article on fibrous septa and cellulite, where impaired lymphatic flow and connective tissue fibrosis were identified as key drivers of tissue dysfunction.
In long-standing lymphoedema, stagnant lymph fluid triggers chronic inflammation, leading to fibrosis of the skin and subcutaneous tissues.
This fibrosis restricts lymphatic vessel mobility and further reduces drainage capacity, creating a vicious cycle.
As discussed in our blog on shockwave therapy for cellulite, fibrotic connective tissue (including fibrous septa) behaves similarly in both cellulite and lymphoedema:
Reduced elasticity.
Impaired fluid movement.
Increased tissue stiffness.
This is where combining manual therapy with mechanical stimulation becomes clinically valuable.
At Mr Salus Sporting Lab, we use EMS Shockwave Therapy, a medical-grade technology traditionally used for musculoskeletal conditions, but increasingly explored for soft-tissue fibrosis and lymphatic congestion.
Shockwave therapy may support lymphoedema management by:
Improving microcirculation.
Mechanically influencing fibrotic tissue.
Enhancing tissue elasticity.
Supporting lymphatic vessel mobility.
When used adjunctively — not as a standalone lymphatic treatment — shockwave therapy can prepare fibrotic tissues to respond more effectively to Manual Lymphatic Drainage.
You can learn more about this technology on our page dedicated to Shockwave Therapy Physiotherapy.
While large-scale trials are still emerging, several case studies and small clinical investigations support this combined approach:
A case series on secondary lower-limb lymphoedema reported reductions in limb circumference and tissue hardness when extracorporeal shockwave therapy was combined with manual lymphatic techniques and compression therapy (PubMed-indexed case reports).
Research investigating shockwave therapy in fibrotic soft-tissue disorders shows improved tissue elasticity and circulation — mechanisms directly relevant to lymphoedema-related fibrosis (PubMed: shockwave and connective tissue remodelling).
Clinical lymphology literature supports MLD as a first-line therapy for both primary and secondary lymphoedema, particularly when combined with other physical therapies rather than used in isolation.
Importantly, shockwave therapy is not a replacement for MLD, but a facilitator, especially in chronic or fibrotic presentations.
We assess:
Type of lymphoedema (primary vs secondary).
Tissue quality (soft vs fibrotic).
Limb volume and symptom severity.
Medical history and contraindications.
MLD forms the foundation of treatment, focusing on:
Proximal lymphatic clearance.
Rerouting fluid toward functional lymph nodes.
Reducing heaviness and discomfort.
In selected cases (especially chronic or fibrotic lymphoedema):
Low-frequency, moderate-pressure shockwaves are applied to fibrotic areas.
The aim is tissue softening, not aggressive stimulation.
Always followed by manual lymphatic drainage.
Patients are guided on:
Movement and circulation strategies.
Skin care.
Lifestyle factors affecting lymphatic health.
Referral pathways for compression garments, if needed.
This integrated method reflects the same medical-grade physiotherapy philosophy used across our soft-tissue and rehabilitation services.
Secondary lymphoedema (e.g. post-surgical or post-oncology) often responds well to combined manual therapy and mechanical tissue modulation when fibrosis is present.
In both cases, individualisation is essential.
In the limited but growing body of research on shockwave therapy for lymphoedema, studies consistently use more conservative parameters compared to musculoskeletal applications, reflecting the sensitivity of lymphatic and subcutaneous tissues, such as:
Most clinical trials and case series involving secondary lymphoedema (particularly post-mastectomy upper-limb lymphoedema) report low frequencies between 4 and 10 Hz, which allow adequate tissue deformation while minimising discomfort and excessive mechanical stress.
Pressure settings are typically kept low to moderate, most commonly in the range of 1.0 to 2.5 bar for radial shockwave therapy, with the explicit aim of influencing fibrotic subcutaneous tissue and microcirculation rather than deep musculoskeletal structures.
Regarding applicator (header) size, research protocols favour larger radial headers, usually 15–20 mm in diameter, to ensure even energy distribution across oedematous areas and to avoid focal tissue overload.
Treatment doses in lymphoedema studies are generally lower than in tendinopathy trials, with 1,000–2,000 pulses per session per region, applied over multiple sessions (commonly 6–12 sessions) and always combined with Manual Lymphatic Drainage and compression therapy.
Importantly, published research emphasises that shockwave therapy in lymphoedema is used as an adjunct to manual and decongestive therapy, targeting tissue fibrosis, stiffness, and impaired lymphatic mobility, rather than as a standalone treatment.
Before using shockwave therapy, we follow these guidelines:
Not used over active malignancy, infection, or acute inflammation.
Parameters are adapted for lymphatic tissue sensitivity.
All treatments are delivered by trained physiotherapists.
Manual Lymphatic Drainage remains the gold standard for lymphoedema care — but when combined with Shockwave Therapy, hands-on physiotherapy, and clinical reasoning, it becomes even more powerful in managing fibrotic, chronic, or complex cases.
At Mr Salus Sporting Lab, our goal is not just to reduce swelling but to restore tissue health, mobility, and quality of life through an integrated, evidence-informed approach.
If you suffer from persistent swelling, heaviness, or lymphatic dysfunction, book a clinical assessment to explore whether this combined treatment pathway is right for you.